Overview

New Treatment for Nocturnal Enuresis in Children

Status:
RECRUITING
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the role of sulbutiamine in treatment of monosymptomatic nocturnal enuresis in children by using it alone or as a combination therapy with tricyclic antidepressants (imipramine+sulbutiamine).
Phase:
NA
Details
Lead Sponsor:
Sohag University
Treatments:
Imipramine
sulbutiamine